Search for: "Abbott Laboratories" Results 61 - 80 of 981
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2009, 10:18 am by Gene Quinn
In reality, it is hard to characterize Abbott Laboratories as being a "friend" of who they must pay that exorbitant sum to, but I [...] [read post]
18 Jul 2007, 9:22 am
Abbott Laboratories and Andrx Pharmaceuticals have settled their Northern District patent litigation over Andrx's efforts to sell a generic version of Abbott's extended release antibiotic Biaxin XL, Case No.05 C 1490 (discussed at length in the Blog's archives). [read post]
24 May 2012, 11:45 am
Abbott Laboratories, makers of the drug Depakote, will pay $1.6 billion to settle federal and state claims that it illegally marketed the drug for uses not approved by the Federal Drug Administration. [read post]
29 Mar 2011, 9:55 pm by Patent Docs
Abbott Laboratories on March 31, 2011 from 3:00-4:00 PM (ET). [read post]
17 Feb 2016, 3:00 am by Steve Brachmann
Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. [read post]
20 Jun 2011, 2:25 pm
A federal probe recently revealed that the Illinois-based company Abbott Laboratories violated the law by promoting Depakote for unapproved uses. [read post]
23 Apr 2012, 9:59 pm by Patent Docs
Food and Drug Administration on April 2, Abbott Laboratories requested that the FDA refrain from accepting biosimilar applications under the Biologics Price Competition and Innovation Act (BPCIA) that cite reference products (biologics) for which a biologics license application (BLA) was submitted to the FDA prior to March 23, 2010. [read post]
19 Jun 2009, 8:29 am
A dispute brewing in a False Claims Act lawsuit against Abbott Laboratories and other defendants  could have wide-ranging implications for how the Department of Justice handles investigations of qui tam whistleblower complaints. [read post]
12 Jan 2009, 1:27 pm
Skadden and Jones Day advised on Abbott Laboratories' big step forward in the eye care business. [read post]
20 Jan 2023, 5:53 pm by Dan Flynn
Abbott Laboratories’ infant-formula plant in Sturgis, MI, is the apparent target of a federal criminal investigation by the U.S. [read post]
8 May 2012, 5:03 pm
Yesterday, the Department of Justice announced that Abbott Laboratories Inc. has agreed to plead guilty and pay $1.5 billion to resolve criminal and civil liability resulting from a scheme to promote its prescription drug, Depakote, for uses not approved as safe and effective by the Food and Drug Administration. [read post]
10 Jan 2007, 8:56 pm
Abbott Laboratories is currently fighting antitrust allegations relating to two of its best-selling drugs: Norvir, a protease inhibitor used in AIDS treatment, and Hytrin, a drug used to treat enlarged prostate and hypertension. [read post]
7 Jan 2014, 12:56 am by Ben Vernia
On December 27, the Department of Justice announced that Abbott Laboratories had agreed to pay nearly $5.5 million to resolve civil allegations, originally raised by a whistleblower, that the company had paid kickbacks to physicians for using its medical devices. [read post]
26 Jun 2020, 4:00 am by Kimberly A. Kralowec
Yesterday, the California Supreme Court handed down its opinion in Abbott Laboratories v. [read post]
27 Jul 2011, 3:52 am by Bob Kraft
The cholesteraol drug Niaspan has been a popular one for Abbott Laboratories, but it’s getting some bad publicity these days. [read post]
30 Jun 2023, 1:29 pm by Javier Dominguez
By Daniel Seiden, June 30, 2023 The US Supreme Court revived Friday a whistleblower’s False Claims Act suit alleging that Abbott Laboratories Inc., Arriva Medical LLC, and Alere Inc. improperly billed Medicare for diabetic testing supplies. [read post]